Abstract
Twenty-six healthy children previously immunized (imm) with the Hib capsular polysaccharide (Hib CP) vaccine at age 19 to 38 mos (GM=28 mos; 1 of 26 <24 mos) developed Hib systemic disease at age 22 to 45 mos (GM=32 mos), which was 2 to 44 wks (GH=12.6 wks) after imm. Disease consisted of 16, 6, and 4 cases of meningitis, epiglottitis, and other infections, respectively. Antibody (Ab) to the Hib CP in serial convalescent serum samples collected 24 days-8 mos after infection failed to increase to 1μg/ml in 17 Of the 26 and had a GMT of 0.56μg/ml, which contrasted with Ab of an age-matched control group of Hib infected, nonimm children (GMT=2.7μg/ml, p<.05). IgG2 subclass deficiency was detected in 9 of the 26 and was associated with low or borderline-low levels of IgG and IgA in 5 and 6 of the 9 respectively. Postinfection Ab to the Hib CP was <1 μg/ml in 7 of the 9 with IgG2 deficiency (GMT=0.29μg/ml), but all had normal Ab titers to tetanus and diphtheria toxoids. At present, reimm with the Hib CP and imm with pneumococcal CPs induced poor Ab responses in 1 of 1 and 3 of 3 with IgG2 deficiency, respectively. These findings suggest that a considerable proportion of cases of this new entity - Hib disease after Hib CP imm - is associated with IgG2 subclass deficiency and poor Ab responses to Hib infection.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Insel, R., Gellin, B., Broome, C. et al. 1gG2 SUBCLASS DEFICIENCY PRESENTING AS H. INFLUENZAE B (HIB) DISEASE AFTER IMMUNIZATION WITH HIB VACCINE. Pediatr Res 21 (Suppl 4), 312 (1987). https://doi.org/10.1203/00006450-198704010-00871
Issue Date:
DOI: https://doi.org/10.1203/00006450-198704010-00871